If the risk variant indeed exerts its pathogenic effect through an effect on CDCA7L expression, CDCA7L’s effects on DNA methylation might be involved in the pathogenesis of multiple myeloma. This evidence concerns the gene CDCA7L and plasma cell myeloma.